Abstract:Abstract A subset of children with B cell precursor acute lymphoblastic leukemia (B-ALL) are at high risk for relapse and death. Gene expression profiles in these high-risk B-ALLs is similar to that of Philadelphia chromosome-positive ALL. Approximately half of these Ph-like B-ALL are characterized by genetic defects resulting in overexpression of CRLF2. This defect occurs 5 times more commonly in Hispanic children than others and thus is a significant biological component of pediatric cancer health disparities. CRLF2, together with the IL-7Rα, forms a receptor complex that is activated by the cytokine, TSLP. Receptor complex activation leads to JAK-STAT5 phosphorylation. The activating JAK mutations found in some CRLF2 B-ALL led to speculation that TSLP stimulation is not a factor in CRLF B-ALL. However, we and others have found that TSLP increases STAT5 phosphorylation in CRLF2 B-ALL cells, including those with JAK defects. Our next step was to evaluate the role of TSLP-CRLF2 interactions in vivo in the human-mouse xenograft model. However, mouse TSLP is species-specific and does not activate the human TSLP receptor complex that includes CRLF2. Thus, traditional xenograft models do not provide the TSLP-CRLF2 interactions that may contribute to high risk CRLF2 B-ALL. We engineered immune-deficient NOD/SCID IL-2Rγ null (NSG) mice to express human TSLP (hTSLP+ mice), as well as control mice that lack the TSLP cytokine (hTSLP- mice). Then we used this hTSLP+/- xenograft model system to evaluate the in vivo effects of TSLP on transplanted CRLF2 B-ALL cells harboring a JAK defect (MUTZ5 cell line). Transplanted mice were euthanized at 5 weeks and bone marrow (BM) was harvested. Evaluation of BM by flow cytometry showed that approximately half of the human leukemia cells were apoptotic in mice without TSLP while apoptosis was virtually absent in CRLF2 B-ALL cells harvested from hTSLP+ mice. Next we used Ingenuity Pathway Analysis to identify functions and pathways regulated by TSLP. Primary CRLF2 B-ALL cells were transplanted into hTSLP+ and hTSLP- mice. Whole genome microarray performed on primary human leukemia cells isolated from BM of xenograft mice identified 280 genes that were upregulated and 281 genes that were downregulated (> 2 fold up or downregulated; p Citation Format: Olivia L. Francis, Ruijun Su, Shannalee R. Martinez, Ineavely Baez, Terry-Ann Milford, Ross Fisher, Christopher L. Morris, Xiaobing Zhang, Valeri Filippov, Sinisa Dovat, Kimberly J. Payne. TSLP regulates expression of genes involved in cell survival in a preclinical xenograft model of CRLF2 B-ALL. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3097. doi:10.1158/1538-7445.AM2014-3097

Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P2 hydrolysis in the plasma membrane

Novel Pathogenic OCRL Mutations and Genotype-Phenotype Analysis of Chinese Children Affected by Oculocerebrorenal Syndrome: Two Cases and a Literature Review.

The role of the Lowe syndrome protein OCRL in the endocytic pathway

Novel OCRL mutations in Chinese children with Lowe syndrome

Ruxolitinib/nilotinib Cotreatment Inhibits Leukemia-Propagating Cells in Philadelphia Chromosome-Positive ALL.

Identification of the Ocrl1 Gene Mutations in Two Chinese Families with Lowe'S Syndrome

OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses

Identification of Two Novel Mutations in the Ocrl1 Gene in Two Chinese Families with Lowe Syndrome

Novel Mutation in OCRL Leading to a Severe Form of Lowe Syndrome

Whole‐genome Sequencing Revealed an Interstitial Deletion Encompassing OCRL and SMARCA1 Gene in a Patient with Lowe Syndrome

Clinical features and OCRL mutation analysis in a case of infant Lowe syndrome

A genetic and physiological model of renal dysfunction in Lowe syndrome

ORP4L is Essential for T-cell Acute Lymphoblastic Leukemia Cell Survival

An Acquired Phosphatidylinositol 4-Phosphate Transport Initiates T-cell Deterioration and Leukemogenesis.

Base editing correction of OCRL in Lowe syndrome: ABE-mediated functional rescue in patient-derived fibroblasts

Abstract 3097: TSLP Regulates Expression of Genes Involved in Cell Survival in a Preclinical Xenograft Model of CRLF2 B-ALL

Defective Neurogenesis in Lowe Syndrome is Caused by Mitochondria Loss and Cilia-related Sonic Hedgehog Defects

Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome

The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways

High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia

Obg-Like Atpase 1 Regulates Global Protein Serine/Threonine Phosphorylation In Cancer Cells By Suppressing The Gsk3 Beta-Inhibitor 2-Pp1 Positive Feedback Loop